Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
NITAG documentation
Adults
Clear all
Type of publications
NITAG documentation
(11)
Systematic reviews (SYSVAC)
(1026)
Topics
Agenda & Minutes
(2)
Background paper
(1)
Recommendation
(8)
Regions
Americas
(6)
Europe
(4)
Western Pacific
(1)
Countries
Australia
(1)
Belgium
(2)
Canada
(2)
Germany
(1)
Luxembourg
(1)
United States of America
(4)
Diseases
COVID-19
(3)
Hepatitis A
(1)
Hepatitis B
(1)
Herpes zoster
(3)
Human papillomavirus (HPV)
(2)
Influenza
(2)
Japanese encephalitis
(2)
Meningococcal disease
(1)
Mumps
(1)
Pertussis
(1)
Pneumococcal disease
(5)
Rabies
(1)
Publication date
2023
(1)
2022
(4)
2021
(3)
2018
(1)
2017
(2)
Target population
Adults
(8)
Adolescents
(6)
All age groups
(1)
Children
(22)
Healthcare workers
(4)
Migrants
(1)
Newborn
(8)
Older adults
(10)
Pregnant women
(8)
Risk group
(7)
Available to download in languages
English (EN)
(8)
French (FR)
(3)
11 results found
2023
∙
NACI
Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines
2022
∙
Conseil Supérieur des Maladies Infectieuses
Recommendations for the shingles vaccination
2022
∙
ACIP
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
ACIP
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against pneumococcal disease for adults in Belgium
2021
∙
ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2021
∙
NACI
NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults
2021
∙
Conseil Supérieur de la Santé (CSS)
Non-replicating viral vector vaccines and the Belgian COVID-19 vaccination strategy
2018
∙
ACIP
October 2018 - meeting minutes
2017
∙
STIKO
Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register